233 related articles for article (PubMed ID: 13130392)
1. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
Chatterjee SS; Kondratskaya EL; Krishtal OA
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
3. [Gingkolides and bilobalide: structure, pharmacology, and synthesis].
Sviridov AF
Bioorg Khim; 1991 Oct; 17(10):1301-12. PubMed ID: 1804115
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents.
Ahlemeyer B; Möwes A; Krieglstein J
Eur J Pharmacol; 1999 Feb; 367(2-3):423-30. PubMed ID: 10079019
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death.
Chandrasekaran K; Mehrabian Z; Spinnewyn B; Chinopoulos C; Drieu K; Fiskum G
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S89-94. PubMed ID: 13130395
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.
Kondratskaya EL; Pankratov YV; Lalo UV; Chatterjee SS; Krishtal OA
Neurochem Int; 2004 Feb; 44(3):171-7. PubMed ID: 14568560
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761).
Pietri S; Maurelli E; Drieu K; Culcasi M
J Mol Cell Cardiol; 1997 Feb; 29(2):733-42. PubMed ID: 9140830
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes.
Klein J; Weichel O; Hilgert M; Rupp J; Chatterjee SS; Nawrath H
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S78-83. PubMed ID: 13130393
[TBL] [Abstract][Full Text] [Related]
10. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel.
Kondratskaya EL; Lishko PV; Chatterjee SS; Krishtal OA
Neurochem Int; 2002 Jun; 40(7):647-53. PubMed ID: 11900860
[TBL] [Abstract][Full Text] [Related]
11. Suppression of pacemaker activity by Ginkgo biloba extract and its main constituent, bilobalide in rat sino-atrial nodal cells.
Satoh H
Life Sci; 2005 Nov; 78(1):67-73. PubMed ID: 16182317
[TBL] [Abstract][Full Text] [Related]
12. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity.
Chandrasekaran K; Mehrabian Z; Spinnewyn B; Chinopoulos C; Drieu K; Fiskum G
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):663-9. PubMed ID: 12396077
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide B preferentially blocks chloride channels formed by heteromeric glycine receptors in hippocampal pyramidal neurons of rat.
Kondratskaya EL; Fisyunov AI; Chatterjee SS; Krishtal OA
Brain Res Bull; 2004 May; 63(4):309-14. PubMed ID: 15196656
[TBL] [Abstract][Full Text] [Related]
14. Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices.
Sasaki K; Oota I; Wada K; Inomata K; Ohshika H; Haga M
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Nov; 124(3):315-21. PubMed ID: 10661725
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
16. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
17. Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals.
Wang SJ; Chen HH
Eur J Pharmacol; 2005 May; 514(2-3):141-9. PubMed ID: 15910800
[TBL] [Abstract][Full Text] [Related]
18. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.
Bastianetto S; Zheng WH; Quirion R
J Neurochem; 2000 Jun; 74(6):2268-77. PubMed ID: 10820186
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
Vasseur M; Jean T; DeFeudis FV; Drieu K
Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba.
Klein J; Chatterjee SS; Löffelholz K
Brain Res; 1997 May; 755(2):347-50. PubMed ID: 9175905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
